Diabetes 50:551-557, 2001
© 2001 by the American Diabetes Association, Inc.
Distinction Between Interleukin-1Induced Necrosis and Apoptosis of Islet Cells
Anne Hoorens,
Geert Stangé,
Dejan Pavlovic, and
Daniel Pipeleers
Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium
Interleukin (IL)-1ß is known to cause ß-cell death in isolated rat islets. This effect has been attributed to induction of nitric oxide (NO) synthase in ß-cells and subsequent generation of toxic NO levels; it was not observed, however, in dispersed rat ß-cells. The present study demonstrates that IL-1ß induces NO-dependent necrosis in rat ß-cells cultured for 3 days at high cell density or in cell aggregates but not as single cells. Its cytotoxic condition is not explained by higher NO production rates but might result from higher intercellular NO concentrations in statically cultured cell preparations with cell-to-cell contacts; nitrite levels in collected culture medium are not a reliable index for these intercellular concentrations. Absence of IL-1induced necrosis in rat -cells or in human ß-cells is attributed to the cytokines failure to generate NO in these preparations, not to their reduced sensitivity to NO: the NO donor GEA 3162 (15 min, 50100 µmol/l) exerts a comparable necrotic effect in rat and human - or ß-cells. In preparations in which IL-1ß does not cause ß-cell necrosis, its combination with -interferon (IFN- ) results in NO-independent apoptosis, starting after 3 days and increasing with the duration of exposure. Because IFN- alone was apoptotic for rat -cells, it is proposed that IL-1ß can make ß-cells susceptible to this effect, conceivably through altering their phenotype. It is concluded that IL-1ß can cause NO-dependent necrosis or NO-independent apoptosis of islet cells, depending on the species and on the environmental conditions. The experiments in isolated human ß-cell preparations suggest that these cells may preferentially undergo apoptosis when exposed to IL-1ß plus IFN- unless neighboring nonß-cells produce toxic NO levels.
Abbreviations:
HO 342, Hoechst 33342; IFN- , -interferon; IL, interleukin; iNOS, inducible nitric oxide synthase; NO, nitric oxide; PI, propidium iodide; TNF, tumor necrosis factor

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Montolio, M. Biarnes, N. Tellez, J. Escoriza, J. Soler, and E. Montanya
Interleukin-1{beta} and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation
J. Endocrinol.,
January 1, 2007;
192(1):
169 - 177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Laychock, S. M. Sessanna, M.-H. Lin, and L. D. Mastrandrea
Sphingosine 1-Phosphate Affects Cytokine-Induced Apoptosis in Rat Pancreatic Islet {beta}-Cells
Endocrinology,
October 1, 2006;
147(10):
4705 - 4712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Collier, P. T. Fueger, H. E. Hohmeier, and C. B. Newgard
Pro- and Antiapoptotic Proteins Regulate Apoptosis but Do Not Protect Against Cytokine-Mediated Cytotoxicity in Rat Islets and {beta}-Cell Lines.
Diabetes,
May 1, 2006;
55(5):
1398 - 1406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Eldor, A. Yeffet, K. Baum, V. Doviner, D. Amar, Y. Ben-Neriah, G. Christofori, A. Peled, J. C. Carel, C. Boitard, et al.
Conditional and specific NF-{kappa}B blockade protects pancreatic beta cells from diabetogenic agents
PNAS,
March 28, 2006;
103(13):
5072 - 5077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. Mastrandrea, S. M. Sessanna, and S. G. Laychock
Sphingosine Kinase Activity and Sphingosine-1 Phosphate Production in Rat Pancreatic Islets and INS-1 Cells: Response to Cytokines
Diabetes,
May 1, 2005;
54(5):
1429 - 1436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Luther, E. Davies, D. Muller, M. Harrison, A. J. Bone, S. J. Persaud, and P. M. Jones
Cell-to-cell contact influences proliferative marker expression and apoptosis in MIN6 cells grown in islet-like structures
Am J Physiol Endocrinol Metab,
March 1, 2005;
288(3):
E502 - E509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ohara-Imaizumi, A. K. Cardozo, T. Kikuta, D. L. Eizirik, and S. Nagamatsu
The Cytokine Interleukin-1{beta} Reduces the Docking and Fusion of Insulin Granules in Pancreatic {beta}-Cells, Preferentially Decreasing the First Phase of Exocytosis
J. Biol. Chem.,
October 1, 2004;
279(40):
41271 - 41274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Ling, M. Van de Casteele, J. Dong, H. Heimberg, J.-A. Haefliger, G. Waeber, F. Schuit, and D. Pipeleers
Variations in IB1/JIP1 Expression Regulate Susceptibility of {beta}-Cells to Cytokine-Induced Apoptosis Irrespective of C-Jun NH2-Terminal Kinase Signaling
Diabetes,
October 1, 2003;
52(10):
2497 - 2502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Cao, Z. Gao, C. E. Robert, S. Greene, G. Xu, W. Xu, E. Bell, D. Campbell, Y. Zhu, R. Young, et al.
Pancreatic-Derived Factor (FAM3B), a Novel Islet Cytokine, Induces Apoptosis of Insulin-Secreting {beta}-Cells
Diabetes,
September 1, 2003;
52(9):
2296 - 2303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-A. Haefliger, T. Tawadros, L. Meylan, S. L. Gurun, M.-E. Roehrich, D. Martin, B. Thorens, and G. Waeber
The scaffold protein IB1/JIP-1 is a critical mediator of cytokine-induced apoptosis in pancreatic {beta} cells
J. Cell Sci.,
April 15, 2003;
116(8):
1463 - 1469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bottino, A.N. Balamurugan, S. Bertera, M. Pietropaolo, M. Trucco, and J. D. Piganelli
Preservation of Human Islet Cell Functional Mass by Anti-Oxidative Action of a Novel SOD Mimic Compound
Diabetes,
August 1, 2002;
51(8):
2561 - 2567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. E. Thomas, R. Darwiche, J. A. Corbett, and T. W.H. Kay
Interleukin-1 Plus {gamma}-Interferon-Induced Pancreatic {beta}-Cell Dysfunction Is Mediated by {beta}-Cell Nitric Oxide Production
Diabetes,
February 1, 2002;
51(2):
311 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Piganelli, S. C. Flores, C. Cruz, J. Koepp, I. Batinic-Haberle, J. Crapo, B. Day, R. Kachadourian, R. Young, B. Bradley, et al.
A Metalloporphyrin-Based Superoxide Dismutase Mimic Inhibits Adoptive Transfer of Autoimmune Diabetes by a Diabetogenic T-Cell Clone
Diabetes,
February 1, 2002;
51(2):
347 - 355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Van de Casteele, B. A. Kefas, Z. Ling, H. Heimberg, and D. G. Pipeleers
Specific Expression of Bax-{omega} in Pancreatic {beta}-Cells Is Down-Regulated by Cytokines before the Onset of Apoptosis
Endocrinology,
January 1, 2002;
143(1):
320 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cnop, J. C. Hannaert, A. Hoorens, D. L. Eizirik, and D. G. Pipeleers
Inverse Relationship Between Cytotoxicity of Free Fatty Acids in Pancreatic Islet Cells and Cellular Triglyceride Accumulation
Diabetes,
August 1, 2001;
50(8):
1771 - 1777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Cardozo, H. Heimberg, Y. Heremans, R. Leeman, B. Kutlu, M. Kruhoffer, T. Orntoft, and D. L. Eizirik
A Comprehensive Analysis of Cytokine-induced and Nuclear Factor-kappa B-dependent Genes in Primary Rat Pancreatic beta -Cells
J. Biol. Chem.,
December 21, 2001;
276(52):
48879 - 48886.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|